Raymond James Financial Services Advisors, Inc. Haemonetics Corp Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$111.01 - $139.48 $188,272 - $236,558	-1,696 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$88.75 - $119.95 $150,520 - $203,435	1,696 New	1,696 $201,000
Q4 2018 Feb 11, 2019	SELL	$90.66 - $116.63 $207,520 - $266,966	-2,289 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$89.96 - $114.58 $205,918 - $262,273	2,289 New	2,289 $262,000

Others Institutions Holding HAE

# of Institutions

334

Shares Held

54.2M

Call Options Held

689K

Put Options Held

345K

Black Rock Inc. New York, NY

5.96M
Shares

$375 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$326 Million
0.01% of portfolio
Capital Research Global Investors Los Angeles, CA

4.44M
Shares

$280 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

4.2M
Shares

$265 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

4.03M
Shares

$254 Million
0.26% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.23B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account